Dr. Steven Zeitels is a preeminent Laryngeal Surgeon & has pioneered many of the state-of-the-art operative techniques to restore human voice for benign and malignant lesions and diseases. He has published & lectured extensively on this subject.
- Centers & Specialties
- Clinical Interests
- Cancer of the throat and vocal cords
- Performing and professional voice
- Laryngeal stenosis
- Vocal cord paralysis
- Laryngeal Surgery
- Medical Education
- MD, Boston University School of Medicine
- Residency, Boston Medical Center
- Fellowship, Boston Medical Center
- Board Certifications
- Boston: Massachusetts General Hospital
- Insurances Accepted
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- BMC HealthNet Mass Health MCO/ACO
- Commonwealth Care Alliance
- Medicare - ACD
- OSW - Maine
- OSW - New Hampshire
- OSW - New York
- OSW - Rhode Island
- OSW - Vermont
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
See Pubmed.gov: "Zeitels SM"[Author]
A Massachusetts General Hospital research team finds that the remarkable recent increase in vocal-cord cancer in young adults appears to be the result of infection with strains of human papilloma virus that also cause cervical cancer and other malignancies.
A retrospective review of microsugery performed in 18 Grammy Award-winning performers treated by surgeons at the Massachusetts General Hospital Division of Laryngeal Surgery has revealed insights into the treatment and management of vocal-cord disease in elite performers.
Statement regarding treatment of Sam Smith by Steven Zeitels, MD.
The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer, developed at the MGH and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients’ tumors while avoiding the damage to vocal quality caused by radiotherapy or by conventional laser or cold-instrument surgery.
The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer, developed at MGH and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients’ tumors while avoiding the damage to vocal quality caused by conventional treatments.
MGH surgeons have developed a new technique for reconstructing the larynx after surgery for advanced cancer. The approach uses cryopreserved aortas from deceased donors to replace removed larynx tissue and allows some patients to avoid a permanent tracheotomy and maintain voice and swallowing function.
One Bowdoin Square
Boston, MA 02114-2927
Phone 1: 617-726-1444
Phone 2: 617-726-0218